Cardiovascular diseases are a major cause of disability and they are currently responsible
for a significant number of deaths in a large percentage of the world population. A large …

Cardiovascular diseases claim a number of lives globally; many of which are preventable.
With the increase in diets that consist of high saturated fat, salt, and sugar, people often …

Nanotechnology is poised to have an increasing impact on cardiovascular health in coming
years. Diagnostically, multiplexed point‐of‐care devices will enable rapid genotyping and …

Cardiovascular diseases (CVDs) are still one of the main causes of death. In recent years,
nanotechnology has offered new materials and strategies for more effective and safe …

Cardiovascular diseases (CVDs) are one of the most important causes of mortality and
affecting the health status of patients. At the same time, CVDs cause a huge health and …

Cardiovascular disease (CVD) is comprised of a group of disorders affecting the heart and
blood vessels of the human body and is one of the leading causes of death worldwide …

Bioactive compounds are comprised of small quantities of extra nutritional constituents
providing both health benefits and enhanced nutritional value, based on their ability to …

Cardiovascular diseases (CVDs) represent the most important epidemic of our century, with
more than 37 million patients globally. Furthermore, CVDs are associated with high …

Nano-medicines that include nanoparticles, nanocomposites, small molecules, and
exosomes represent new viable sources for future therapies for the dysfunction of …

Cardiovascular diseases (CVDs) constitute a predominant cause of both global mortality
and morbidity. To address the challenges in the early diagnosis and management of CVDs …